| [1] |
Gao L, Sun Y H. Laboratory diagnosis and treatment of Mycoplasma pneumoniae infection in children:a review[J]. Ann Med, 2024, 56(1):2386636. doi:10.1080/07853890.2024.2386636.
|
| [2] |
Wang Z Y, Peng Y Y, Yang S, et al. Risk factors for complications of Mycoplasma pneumoniae pneumonia in hospitalized children in China:a systematic review and meta-analysis[J]. BMC Pediatr, 2024, 24(1):810. doi:10.1186/s12887-024-05279-9.
|
| [3] |
Piao M Y, Liu N, Meng F Y, et al. Clinical analysis of Mycoplasma pneumoniae pneumonia combined with adenovirus infection in children with lobar pneumonia[J]. Eur J Clin Microbiol Infect Dis, 2025, 44(10):2331-2341. doi:10.1007/s10096-025-05194-6.
|
| [4] |
Zhang L L, Xiao Y, Zhang G L, et al. Identification of priority pathogens for aetiological diagnosis in adults with community-acquired pneumonia in China:a multicentre prospective study[J]. BMC Infect Dis, 2023, 23(1):231. doi:10.1186/s12879-023-08166-3.
|
| [5] |
Deng C H, Li T Q, Zhang W, et al. Targeting inflammasome activation in viral infection:a therapeutic solution?[J]. Viruses, 2023, 15(7):1451. doi:10.3390/v15071451.
|
| [6] |
Baik J S, Seo Y N, Lee Y C, et al. Involvement of the p38 MAPK-NLRC4-caspase-1 pathway in ionizing radiation-enhanced macrophage IL-1β production[J]. Int J Mol Sci, 2022, 23(22):13757. doi:10.3390/ijms232213757.
|
| [7] |
中华人民共和国国家卫生健康委员会. 儿童肺炎支原体肺炎诊疗指南(2023年版)[J]. 国际流行病学传染病学杂志, 2023, 50(2):79-85.
|
|
National Health Commission of the People's Republic of China. Guidelines for the diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children(2023 edition) [J]. International Journal of Epidemiology and Infectious Disease, 2023, 50(2):79-85. doi:10.3760/cma.j.cn331340-20230217-00023.
|
| [8] |
国家卫生健康委员会, 国家中医药管理局. 儿童腺病毒肺炎诊疗规范(2019年版)[J]. 传染病信息, 2019, 32(4):293-298.
|
|
National Health Commission of the People's Republic of China, National Administration of Traditional Chinese Medicine. Diagnosis and treatment guidelines for adenovirus pneumonia in children (2019 edition)[J]. Infectious Disease Information, 2019, 32(4):293-298. doi:10.3969/j.issn.1007-8134.2019.04.002.
|
| [9] |
Niu D D, Gao Y X, Zhang Y L, et al. Systematic review and meta-analysis of the association between clinical severity and co-infection of human adenovirus with other respiratory pathogens in children[J]. J Med Virol, 2025, 97(5):e70370. doi:10.1002/jmv.70370.
|
| [10] |
Yi X W, Jia W Y, Li W Y, et al. Diagnostic value of cytokines in severe childhood Mycoplasma pneumoniae pneumonia combined with adenovirus infection[J]. Ital J Pediatr, 2024, 50(1):92. doi:10.1186/s13052-024-01661-6.
|
| [11] |
Wei J F, Wu S L, Jin X F, et al. Association of Mycoplasma pneumoniae coinfection with adenovirus pneumonia severity in children[J]. Allergol Immunopathol (Madr), 2022, 50(1):31-36. doi:10.15586/aei.v50i1.476.
|
| [12] |
Paudel S, Ghimire L, Jeansonne D, et al. NLRC4 deficiency improves host protection during sepsis by regulating macrophage and T-cell responses[J]. J Immunol, 2026, 215(1):vkaf272. doi:10.1093/jimmun/vkaf272.
|
| [13] |
An Y P, Zhai Z H, Wang X, et al. Targeting Desulfovibrio vulgaris flagellin-induced NAIP/NLRC4 inflammasome activation in macrophages attenuates ulcerative colitis[J]. J Adv Res, 2023, 52:219-232. doi:10.1016/j.jare.2023.08.008.
|
| [14] |
Parveen S, Bhat C V, Sagilkumar A C, et al. Bacterial pore-forming toxin pneumolysin drives pathogenicity through host extracellular vesicles released during infection[J]. iScience, 2024, 27(8):110589. doi:10.1016/j.isci.2024.110589.
|
| [15] |
Hardy K S, Tuckey A N, Housley N A, et al. The Pseudomonas aeruginosa type III secretion system exoenzyme effector ExoU induces mitochondrial damage in a murine bone marrow-derived macrophage infection model[J]. Infect Immun, 2022, 90(3):e00470-e00421. doi:10.1128/IAI.00470-21.
|
| [16] |
Zhang Y, Zhang G Y, Dong B, et al. Pyroptosis of pulmonary fibroblasts and macrophages through NLRC4 inflammasome leads to acute respiratory failure[J]. Cell Rep, 2025, 44(4):115479. doi:10.1016/j.celrep.2025.115479.
|
| [17] |
Zhao Y, Zhu H S, Li J Q, et al. T3SS translocon induces pyroptosis by direct interaction with NLRC4/NAIP inflammasome[J]. ELife, 2025, 13:RP100820. doi:10.7554/eLife.100820.
|
| [18] |
Song D, Wei W F, Zhang J, et al. The mechanism of baicalin in the treatment of Mycoplasma pneumoniae pneumonia by regulating NLRP3/caspase-1 signaling pathway[J]. Immunol Invest, 2025, 54(4):560-572. doi:10.1080/08820139.2025.2450244.
|
| [19] |
Song Z, Han C G, Luo G Z, et al. Yinqin Qingfei granules alleviate Mycoplasma pneumoniae pneumonia via inhibiting NLRP3 inflammasome-mediated macrophage pyroptosis[J]. Front Pharmacol, 2024, 15:1437475. doi:10.3389/fphar.2024.1437475.
|
| [20] |
Amaral M P, Cardoso F D, de Farias I S, et al. NAIP/NLRC4 inflammasome participates in macrophage responses to Trypanosoma cruzi by a mechanism that relies on cathepsin-dependent caspase-1 cleavage[J]. Front Immunol, 2023, 14:1282856. doi:10.3389/fimmu.2023.1282856.
|
| [21] |
江伟艺, 邓子龙, 赵望泓. NLRC4在具核梭杆菌诱导巨噬细胞焦亡中发挥调控作用[J]. 南方医科大学学报, 2022, 42(10):1560-1565.
|
|
Jiang W Y, Deng Z L, Zhao W H. NLRC 4 plays a regulatory role in F. nucleatum-induced pyroptosis in macrophages[J]. Journal of Southern Medical University, 2022, 42(10):1560-1565. doi:10.12122/j.issn.1673-4254.2022.10.17.
|